National NTAGI's COVID Working Group To Review SII's Covovax Data For Use In 12 Year Olds And Above BY Outlook Web Desk
National Covid: Govt Panel Recommends Permission For Phase-3 Trial Of Covovax As Booster Dose In Adults BY Outlook Web Desk
